You are here: Industry Insights > Acquisition

News List

Croda Acquires Vaccine Adjuvant Specialist Brenntag Biosector americanpharmaceuticalreview
December 19, 2018
Croda has signed a definitive agreement with Brenntag Nordic A/S to acquire Brenntag Biosector, for a total consideration of €72 million in cash....
Grünenthal buys certain rights to AZ’s Nexium and Vimovo for $922m pharmaphorum
December 18, 2018
AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million.
Merck to buy animal health firm Antelliq for $2.4bn pharmaphorum
December 18, 2018
Merck & Co is to buy animal health firm Antelliq Group for $2.4 billion in a bid to bolster this fast-growing business unit.Antelliq, which is majority owned by private investors BC Partners....
Astellas buys Potenza Therapeutics for up to $405m pharmaceutical-technology
December 18, 2018
Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405m.
Lilly Acquires Hydra Biosciences’ Pain Asset contractpharma
December 18, 2018
Eli Lilly and Co. has entered an agreement with Hydra Biosciences to acquire all assets related to Hydra's preclinical program of TRPA1 antagonists, part of the Transient Receptor Potential (TRP) family of ion channels being studied for the potential trea
CX Partners acquires equity stake in Veeda Clinical Research expressbpd
December 17, 2018
CX Partners acquires equity stake in Veeda Clinical Research
WuXi AppTec eyes acquisitions after $1bn Hong Kong, S.A.R., China IPO pharmaphorum
December 17, 2018
Chinese biotech WuXi AppTec has completed its listing on Hong Kong, S.A.R., China’s HKEX, raising $967m just months after making its debut on the Shanghai exchange.
Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals pharmaceutical-technology
December 17, 2018
Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered a definitive agreement to acquire select assets of Synergy Pharmaceuticals for around $200m and certain assumed liabilities.....
AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals pharmafocusasia
December 14, 2018
AMAG Pharmaceuticals, Inc. today announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., a private biopharmaceutical company......
Masco Group Acquires High Purity division of MarCor americanpharmaceuticalreview
December 13, 2018
Stilmas has acquired the High Purity division of MarCor, based in Burlington, Ontario, Canada. The transaction became effective on November 1, 2018.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page